Almontys, Boardroom

Almonty's Boardroom Shuffle Is Settled; Its Korean Listing and Sangdong Timetable Are Not

Published on 11/22/2026 at 07:10 | Editorial boerse-global.de
Almonty named Bae and Rudyk as independent directors, but its Korea Exchange listing remains an intention. Shares fell 16% to €5.82 amid a broad US selloff.
Almontys, Boardroom, Shuffle, Settled;, Its, Korean, Listing, Sangdong, Timetable, Are Illustration mit AI erstellt.

Almonty Industries has completed one piece of corporate business while leaving a larger one hanging. The tungsten miner named Eugene Bae and James Rudyk as independent directors on 17 November, the same day it disclosed its intention to pursue a listing on the Korea Exchange, subject to approval from the exchange and regulators. David Hanick and Andrew Frazer are set to leave the board on 31 December 2026.

The two announcements sit at very different stages of completion. The board appointments are done and dusted. The Korean listing remains a stated ambition, and that distinction matters for anyone trying to read the company's direction.

A 16% Slide With a Broader Backdrop

Friday brought a sharp move in the share price: the stock fell 16% to €5.82. The decline coincided with a broad selloff in the US equity market, which the Associated Press reported was led by AI-related stocks. In other words, the drop landed on a day when risk appetite was already under pressure across the board.

Analysts, meanwhile, have been redrawing their models. GBC kept its buy rating on Friday but now expects the production ramp-up at Sangdong to arrive roughly three quarters later than previously assumed. The research house cut its 2026 revenue forecast to US$125.9 million from US$365.9 million, and trimmed its 2027 estimate to US$520 million from US$1.32 billion.

Should investors sell immediately? Or is it worth buying Almonty?

Sphene Capital had already moved on 16 November, lowering its price target to US$22.40 from US$26.40 following the nine-month figures. It, too, reaffirmed its buy recommendation.

What the Third Quarter Actually Showed

The operating reference point remains the 12 November report for the third quarter of 2026. Almonty posted revenue of C$41.9 million, adjusted EBITDA of C$14.6 million and net income of C$50.2 million. For judging the underlying business, adjusted EBITDA is the more appropriate yardstick — the net profit figure is considerably higher and the two metrics should not be treated as interchangeable.

On the production side, Sangdong generated its first tungsten concentrate in September, according to the company. More than 90% of Phase I output was already tied up under contract.

The Listing Question Is the One to Watch

Whether Almonty converts its Korean ambition into a confirmed next step is the decisive test. A second trading venue would widen the investor base and improve access to the stock — a tangible benefit, though one that would not by itself translate into higher revenue or earnings. Until the company confirms something beyond an expressed intention, the broader-access scenario belongs in the realm of possibility rather than in any assessment of what has already been achieved. The board changes, for their part, do nothing to advance the exchange plans.

Almonty at a turning point? This analysis reveals what investors need to know now.

A Canadian Lawsuit Runs in Parallel

Then there is the dispute with Deutsche Rohstoff, which has sued Almonty in Canada for around US$67 million. The claim concerns, among other things, rights to 3.5 million conversion shares and repayment of outstanding promissory notes. Almonty has filed a counterclaim relating to shares connected with the 2014 sale of the Wolfram Camp mine. The demand should not be treated as a certain cash outflow, but it remains relevant to investors because it touches both repayments and share rights.

The next scheduled date on the corporate calendar is the board transition at the end of 2026, when Hanick and Frazer are due to step down. A separate confirmation of the next step toward the Korea Exchange would be the real catalyst. A boardroom handover alone would not constitute progress on the listing front. As long as the Korean plan stays at the level of intent, the quarterly numbers carry the operating case; a confirmed move on the exchange would give the wider-investor-access scenario real weight, while any fallout from the litigation would have to be judged on its own terms.

Ad

Almonty Stock: New Analysis - 22 November

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...

Disclaimer...
en | CA0203987072 | ALMONTYS | boerse | 70543899 |